Christoph U. Correll, MD
Christoph U. Correll, MD
Zucker Hillside Hospital
- Advisory Board: AbbVie Inc.; Actavis; Genentech, Inc.; Hoffmann-La Roche Inc.; IntraCellular Therapies; Lundbeck Inc; Otsuka America Pharmaceutical, Inc.; Reviva Labs, Inc.; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.
- Consultant: AbbVie Inc.; Actavis; Alkermes; Bristol-Myers Squibb; Eli Lilly and Company; Genentech, Inc.; Gerson Lehrman Group; Hoffmann-La Roche Inc.; IntraCellular Therapies; Janssen Pharmaceuticals, Inc.; Lundbeck Inc; MedAvante; Medscape, LLC.; Otsuka America Pharmaceutical, Inc.; Pfizer Inc.; ProPhase Labs, Inc.; Reviva Labs, Inc.; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; Takeda Pharmaceuticals U.S.A., Inc.
- Grant Support: Bristol-Myers Squibb; Otsuka America Pharmaceutical, Inc.; Takeda Pharmaceuticals U.S.A., Inc.
- Research Support: Bristol-Myers Squibb; Otsuka America Pharmaceutical, Inc.